Lung Cancer Research Foundation Opens Grant Applications for 2026
Lung Cancer Research Grant Mechanisms Open for Submission
NEW YORK — The Lung Cancer Research Foundation (LCRF) has officially opened its funding opportunities for 2026, inviting applications for vital research projects dedicated to combating lung cancer.
Despite being recognized as the top cause of cancer mortality for both men and women globally, lung cancer research suffers from persistent underfunding. The establishment of LCRF aims to bridge these critical gaps in financial support for lung cancer research, especially as funding resources remain unpredictable. By collaborating with organizations and individuals that share their passion, LCRF seeks to enhance the progress made thus far in the field of lung cancer research.
Funding Mechanisms to Enhance Lung Cancer Research
LCRF provides primary funding mechanisms designed to support researchers striving to tackle significant challenges in lung cancer, such as improving early detection methods, deepening the understanding of lung cancer biology, addressing drug resistance, and innovating treatment strategies.
One of the key funding opportunities is the Research Grant on Prevention and Early Detection in Lung Cancer. This initiative focuses on identifying and developing techniques for early detection and prevention of lung cancer while also exploring the processes that may lead to pre-cancerous conditions in the lung tissue. Early detection plays a crucial role in improving the prognosis for lung cancer patients, making this research vital. Advances in molecular screening are especially critical in this regard, encouraging research that can lead to innovative prevention and early detection methods.
Leading Edge Research Grant
The Leading Edge Research Grant targets groundbreaking projects within a wide range of researchers' pursuits — including basic, clinical, epidemiological, and health services research. This grant aims to fill the research funding void and facilitate better outcomes for individuals diagnosed with lung cancer. The focus is on innovative concepts and methods that could significantly enhance the lives of those affected by lung cancer and their treatment providers.
Overcoming Resistance Grant
Through the Research Grant on Overcoming Resistance in Lung Cancer, LCRF supports research focused on understanding and mitigating resistance to therapy in lung cancer patients. With numerous targeted therapies and immunotherapies emerging over the past decade, understanding the mechanisms of drug resistance becomes essential. This particular grant mechanism intends to boost knowledge around the challenges associated with drug resistance and to discover means to prevent or manage these barriers effectively.
“The opening of LCRF's Requests for Proposals marks a new year full of promise,” says Kathryn O'Donnell, PhD, Chair of LCRF's Scientific Advisory Board. “Every year, we review proposals that present groundbreaking ideas aimed at finding innovative solutions to lung cancer's complexities. These submissions bring new hopes for people living with lung cancer.”
Colleen Conner Ziegler, a lung cancer survivor and LCRF board chair, expressed profound admiration for the innovative proposals received. “Witnessing the scientific advancements from their infancy and the opportunity to promote meaningful developments for the lung cancer community is incredibly fulfilling,” Ziegler remarked.
Selected grant projects will receive $150,000 over two years, following a two-step review process. Letters of Intent must be submitted by a specified deadline, and shortlisted candidates will be invited to submit full proposals for rigorous evaluation.
About the Lung Cancer Research Foundation
The Lung Cancer Research Foundation (LCRF) stands as a leading nonprofit dedicated to supporting innovative research that aims to extend the lives and enhance the quality of life for lung cancer patients. Focused on improving outcomes for lung cancer, LCRF has funded over 450 research initiatives, amounting to nearly $53 million, representing the most funding given by any nonprofit for lung cancer research. For detailed information regarding the LCRF grant program and available funding opportunities, please visit LCRF.org/research.
Contact:
Sheila Sullivan
Sr. Director, Marketing and Communications
Frequently Asked Questions
What is the Lung Cancer Research Foundation?
The Lung Cancer Research Foundation is a leading nonprofit organization that funds research aimed at improving outcomes for lung cancer patients.
What funding opportunities are available for 2026?
LCRF offers several funding mechanisms, including grants focused on prevention, early detection, overcoming resistance, and innovative research.
How much do grant recipients receive?
Selected researchers can receive up to $150,000 over a two-year period for their projects.
When is the submission deadline for Letters of Intent?
Letters of Intent must be submitted by a specific deadline, typically detailed on LCRF's official website.
How has LCRF supported lung cancer research in the past?
To date, LCRF has funded over 450 research projects, contributing nearly $53 million to lung cancer research initiatives.
